Skip to main content

Table 1 A 2 × 2 contingency table for disproportionality analysis

From: The real-world safety profile of empagliflozin: a disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database

 

Drug related AEs

Non-drug related AEs

Total

Drug

a

b

a + b

Non-drug

c

d

c + d

Total

a + c

b + d

a + b + c + d

  1. Abbreviations AEs adverse events
Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us